The effects of Hormone Replacement Therapy (HRT) on the human eye

Harefuah

Volumn 141, Issue 3, 2002, Pages 287-291+312

  Lang, Yaron ^a   Lang, Nessia ^a   Ben Ami, Moshe ^a   Garzozi, Hanna ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Aging macular degeneration; Dry eye; Estrogen; Hormone replacement therapy; Intraocular pressure

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

AGING; DRY EYE; EYE DISEASE; HORMONE SUBSTITUTION; HUMAN; INTRAOCULAR PRESSURE; POSTMENOPAUSE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW;

CATARACT; ESTROGEN REPLACEMENT THERAPY; EYE; EYE DISEASES; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 0036077330     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause
2. Estrogen and postmenopausal estrogen/progestin therapy: Effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production
3. National Osteoporosis Foundation, Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis
4. Menopausal connective tissue changes and Alzheimer's disease
5. Effects of estrogen on urethral junction in women with urinary incontinence
6. Effects of estrogen, androgen and progestin on sexual psychophysiology and behavior in postmenopausal women
7. Women's attitude towards menopause and hormone replacement therapy
8. Selective estrogen receptor modulators in reproductive medicine and biology
9. Estrogen receptor in the human eye: Influence of gender and age on gene expression
10. Immunohistochemical evidence for estrogen receptors in meibomian glands
11. Expression of estrogen receptor alpha and beta in the mouse cornea
12. Hormone biosynthesis, metabolism and mechanism of action
13. Ophthalmic complaints as a climacteric symptom
14. A survey of ocular complaints in postmenopausal women
15. Treatment of menopausal keratoconjunctivitis sicca with topical oestradiol
16. Menopause and tear function: The influence of prolactin and sex hormones on human tear production
17. Conjunctiva is an estrogen-sensitive epithelium
18. Relation of hormone and menopausal status to outcomes following excimer laser photorefractive keratectomy in women
19. Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy
20. Hormone replacement therapy and intraocular pressure
21. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma
22. Cataracts and macular degeneration in older americans
23. Epidemiologic associations with nuclear, cortical and posterior subcapsular cataracts
24. The Beaver Dam Eye Study. Is there evidence of an estrogen effect on age-related lens opacities?
25. The Blue Mountains Eye Study. Hormone replacement therapy, reproductive factors and cataract
26. Effects of estrogen use on lens transmittance in postmenopausal women
27. Estrogens as antioxidants
28. Estrogen protects lenses against cataract induced by transforming growth factor beta (TGFbeta)
29. Influence of 17b estradiol and progesterone on the rat ocular lens
30. Protective effects of estrogen in a rat model of age-related cataracts
31. Estrogen replacement therapy: Effects on retrobulbar hemodynamics
32. The Eye Disease Case-Control Study Group, Risk factors for central retinal vein occlusion
33. Central retinal vascular occlusion associated with oral contraceptives
34. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study
35. Macular degeneration and early menopause: A case-control study
36. The Eye Disease Case-Control Study Group, Risk factors for neovascular age-related macular degeneration
37. Ocular blood flow velocity in age-related macular degeneration
38. Systemic risk factors for idiopathic macular holes: A case-control study
39. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
40. Estrogen replacement therapy and the risk of venous thrombosis